Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This dual-action approach provides a novel pathway for managing diabetes, diverging from the singular GLP-1 receptor agonism seen in Semaglutide based treatments
Under the brand name Ozmepic, it's approved to treat type 2 diabetes, while under the brand name Wegovy, it's approved for weight loss
Key steps: Confirm Wegovy is on your specific plan's formulary Meet PA requirements (BMI, lifestyle documentation) Work with your doctor to submit the PA Bottom line: Call the number on your card to confirm coverage before your doctor submits the PA
Use 70 percent isopropyl alcohol wipes
Try Again
US$ 27.12
US$ 27.18
US$ 29.32
